Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014143 · ClinicalTrials.gov registry record · Phase 2
Evaluating Commercial Anti-Plaque Products and Oral Rinse
A Phase 2 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT01014143: Completed Phase 2 study, sponsored by Colgate Palmolive.
NCT01014143 is a Phase 2 study that has completed, run by Colgate Palmolive. The registered enrollment target is 26 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01014143, a Phase 2 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
Clinical research study to determine the anti-plaque efficacy of commerical dentifrices and an oral rinse.
Primary Outcome
Plaque scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque,3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
Interventions
- DRUG Fluoride
- DRUG Chlorhexidine digluconate
- DRUG Fluoride, triclosan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
What the finished NCT01014143 record still lists
NCT01014143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which Fluoride is the first listed.
NCT01014143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01014143 about?
NCT01014143 is a clinical study titled "Evaluating Commercial Anti-Plaque Products and Oral Rinse". Clinical research study to determine the anti-plaque efficacy of commerical dentifrices and an oral rinse.
What is the current status of trial NCT01014143?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2007-08. Estimated completion is 2007-09.
What interventions are being tested in trial NCT01014143?
The interventions under investigation include: Fluoride (DRUG), Chlorhexidine digluconate (DRUG), Fluoride, triclosan (DRUG).
Who is sponsoring clinical trial NCT01014143?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01014143's enrollment target sits among peer trials
26 1708th of 2000 higher than 282 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia